Glaucoma Treatment System is available for the surgical management of refractory glaucomas, including cases where previous surgical treatment did not work, cases of primary open-angle …

Oct 10, 2017 · The XEN ® 45 Gel Stent is a hydrophilic, non-inflammatory, subconjunctival gelatin stent. FDA cleared in November 2016 for the management of refractory glaucoma, XEN ® …

The XEN ® Glaucoma Treatment System (XEN ® 45 Gel Stent preloaded into a XEN ® Injector) is indicated for the management of refractory glaucomas, including cases where previous …

XEN®45 Gel Stent; preloaded into a XEN ® Injector The XEN ® 45 Gel Stent is a glaucoma implant designed to reduce intraocular pressure in eyes suffering from refractory glaucoma.

Oct 19, 2023 · XEN ®-45 implantation provides an additional outflow pathway to the subconjunctival space via the stent, whereas Trabectome ® surgery only reduces outflow …

Jan 18, 2018 · In this multicenter study, investigators evaluated the performance and safety of the Xen 45 ab interno gelatin stent (Allergan) for refractory glaucoma through a 12-month follow …

Sep 4, 2023 · Purpose: To evaluate 5-year outcomes of XEN 45 gel stent implantation (XEN) in patients with open angle glaucoma. Methods: This is a prospective, single-center, …

Jul 1, 2023 · Marcos-Parra et al. reviewed three-year data to analyze the safety and effectiveness of the XEN 45 Gel Stent (Allergan), with or without concomi­tant phacoemulsification (phaco), …

Nov 21, 2017 · 该研究是一项多中心的研究，旨在对一种房水引流阀（XEN 45, Allergan）的安全性及降眼压效果进行评估，通过调查问卷对患者术后12个月后的生活质量情况进行评估并对结 …

The XEN received approval from the U.S. Food and Drug Administration (FDA) in November 2016 and launched in the U.S. in early 2017. The translimbal implant targeting the subconjunctival …